癌症中WDR77的作用:不仅仅是一个PRMT5交互因子
Isaac Silverman1, Aaron Shaykevich1,2, Radhashree Maitra1
1Department of Biology, Yeshiva University, New York, New York.
Molecular cancer research : MCR
|January 24, 2025
概括
WD重复域77蛋白 (WDR77) 调节了各种癌症途径,超出了它在基因素甲基化中的已知作用. 它在细胞周期,转录和荷尔蒙信号传递中的上下文依赖功能为癌症治疗提供了新的治疗点.
科学领域:
- 分子生物学分子生物学
- 癌症生物学 癌症生物学
- 细胞信号传输 细胞信号传输
背景情况:
- WD重复域77蛋白 (WDR77) 与癌症进展有关.
- 已知的WDR77的功能涉及与蛋白质氨酸甲基转移酶5 (PRMT5) 在基因素甲基化中的相互作用.
- 新出现的证据表明,WDR77的作用超出了PRMT5,影响了各种细胞过程.
研究的目的:
- 阐明WDR77在癌症中的多方面的作用.
- 探索WDR77的功能,独立于它与PRMT5.5的相互作用.
- 突出WDR77作为瘤学的潜在治疗点.
主要方法:
- 对WDR77已知的相互作用和功能的文献综述和分析.
- 检查WDR77在mRNA翻译,染色体组合,细胞循环调节和细胞亡中的参与.
- 研究WDR77在TGFβ等信号通路中的作用及其与转录因子 (例如E2F) 和激素受体的相互作用.
主要成果:
- WDR77调节细胞周期的进展,特别是G1阶段过渡.
- WDR77影响各种瘤性途径,包括TGFβ信号传递和类固醇激素受体活性.
- WDR77表现出取决于环境的双重作用,根据其细胞局部 (细胞核与细胞质) 促进或抑制瘤生长.
结论:
- WDR77通过各种细胞机制具有广泛的致癌潜力,独立于PRMT5.5.
- 由于WDR77的动态和特定环境的功能,它被认为是一个有前途的治疗点.
- 准WDR77相互作用或局部化可能会导致新的癌症治疗策略.
相关概念视频
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Non-Canonical Wnt Signaling Pathways
7.2K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.2K
Canonical Wnt Signaling Pathway
8.7K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.7K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K


